115 related articles for article (PubMed ID: 22469295)
1. A gene nanocomplex conjugated with monoclonal antibodies for targeted therapy of hepatocellular carcinoma.
Wang JL; Tang GP; Shen J; Hu QL; Xu FJ; Wang QQ; Li ZH; Yang WT
Biomaterials; 2012 Jun; 33(18):4597-607. PubMed ID: 22469295
[TBL] [Abstract][Full Text] [Related]
2. Construction of a star-shaped copolymer as a vector for FGF receptor-mediated gene delivery in vitro and in vivo.
Li D; Ping Y; Xu F; Yu H; Pan H; Huang H; Wang Q; Tang G; Li J
Biomacromolecules; 2010 Sep; 11(9):2221-9. PubMed ID: 20704346
[TBL] [Abstract][Full Text] [Related]
3. An oligopeptide ligand-mediated therapeutic gene nanocomplex for liver cancer-targeted therapy.
Liu M; Li ZH; Xu FJ; Lai LH; Wang QQ; Tang GP; Yang WT
Biomaterials; 2012 Mar; 33(7):2240-50. PubMed ID: 22177837
[TBL] [Abstract][Full Text] [Related]
4. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
5. Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface.
Li D; Wang QQ; Tang GP; Huang HL; Shen FP; Li JZ; Yu H
J Zhejiang Univ Sci B; 2006 Nov; 7(11):906-11. PubMed ID: 17048306
[TBL] [Abstract][Full Text] [Related]
6. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
[TBL] [Abstract][Full Text] [Related]
7. FGF receptor-mediated gene delivery using ligands coupled to polyethylenimine.
Li D; Yu H; Huang H; Shen F; Wu X; Li J; Wang J; Cao X; Wang Q; Tang G
J Biomater Appl; 2007 Sep; 22(2):163-80. PubMed ID: 17255154
[TBL] [Abstract][Full Text] [Related]
8. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
[TBL] [Abstract][Full Text] [Related]
10. [Nanoparticle-mediated endostatin gene therapy targeting hepatocellular carcinoma utilizing heat-inducible promoter].
Zhou JJ; Chen RF; Li ZH; Zhou QB; Tang QB; He XY; Lu HW; Guo N
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):795-9. PubMed ID: 19595115
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobic poly (amino acid) modified PEI mediated delivery of rev-casp-3 for cancer therapy.
Fu C; Lin L; Shi H; Zheng D; Wang W; Gao S; Zhao Y; Tian H; Zhu X; Chen X
Biomaterials; 2012 Jun; 33(18):4589-96. PubMed ID: 22445251
[TBL] [Abstract][Full Text] [Related]
12. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice.
Wolschek MF; Thallinger C; Kursa M; Rössler V; Allen M; Lichtenberger C; Kircheis R; Lucas T; Willheim M; Reinisch W; Gangl A; Wagner E; Jansen B
Hepatology; 2002 Nov; 36(5):1106-14. PubMed ID: 12395320
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles electrostatically coated with folic acid for effective gene therapy.
Kurosaki T; Morishita T; Kodama Y; Sato K; Nakagawa H; Higuchi N; Nakamura T; Hamamoto T; Sasaki H; Kitahara T
Mol Pharm; 2011 Jun; 8(3):913-9. PubMed ID: 21557567
[TBL] [Abstract][Full Text] [Related]
14. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
Zheng F; Shi XW; Yang GF; Gong LL; Yuan HY; Cui YJ; Wang Y; Du YM; Li Y
Life Sci; 2007 Jan; 80(4):388-96. PubMed ID: 17074366
[TBL] [Abstract][Full Text] [Related]
15. Self-assemble gene delivery system for molecular targeting using nucleic acid aptamer.
Kurosaki T; Higuchi N; Kawakami S; Higuchi Y; Nakamura T; Kitahara T; Hashida M; Sasaki H
Gene; 2012 Jan; 491(2):205-9. PubMed ID: 22001405
[TBL] [Abstract][Full Text] [Related]
16. A novel galactose-PEG-conjugated biodegradable copolymer is an efficient gene delivery vector for immunotherapy of hepatocellular carcinoma.
Liu L; Zong ZM; Liu Q; Jiang SS; Zhang Q; Cen LQ; Gao J; Gao XG; Huang JD; Liu Y; Yao H
Biomaterials; 2018 Nov; 184():20-30. PubMed ID: 30195802
[TBL] [Abstract][Full Text] [Related]
17. Heparin-conjugated polyethylenimine for gene delivery.
Jeon O; Yang HS; Lee TJ; Kim BS
J Control Release; 2008 Dec; 132(3):236-42. PubMed ID: 18597881
[TBL] [Abstract][Full Text] [Related]
18. Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes.
Hu Y; Shen Y; Ji B; Yin S; Ren X; Chen T; Ma Y; Zhang Z; Zhang Y
Eur J Pharm Biopharm; 2011 Aug; 78(3):320-5. PubMed ID: 21220007
[TBL] [Abstract][Full Text] [Related]
19. [RNA interference targeting focal adhesion kinase inhibited the growth of human hepatocellular carcinoma sk-hep-1].
Xu WJ; Zhang S; Zhang N; Yang Y; Wei YQ; Deng HX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):455-60. PubMed ID: 21866625
[TBL] [Abstract][Full Text] [Related]
20. Polyethylenimine-based amphiphilic core-shell nanoparticles: study of gene delivery and intracellular trafficking.
Siu YS; Li L; Leung MF; Lee KL; Li P
Biointerphases; 2012 Dec; 7(1-4):16. PubMed ID: 22589059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
